Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sofetabart mipitecan (LY4170156) for the treatment of adult patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have received prior bevacizumab and mirvetuximab soravtansine, if eligible. Sofetabart mipitecan is a […] The post Lilly’s sofetabart mipitecan receives U.S. FDA’s Breakthrough Therapy designation for the treatment of certain patients with platinum-resistant ovarian cancer appeared first on Web-Release.

    Ericsson (NASDAQ: ERIC) is proud to announce a major joint Microsoft-Ericsson development in enterprise mobility – the integration of advanced 5G capabilities directly into Windows 11. The transformative results mean enterprises worldwide – and their workforces – stand to benefit from secure, policy-driven laptop connectivity, simplifying how IT departments manage, protect and scale mobile PC […] The post Microsoft and Ericsson bring enterprise-grade 5G laptop management to Windows 11 appeared first on Web-Release.